BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 4339074)

  • 1. [Dynamic exploration of carbohydrate metabolism in liver cirrhosis. Determination of free fatty acids and insulin in the blood].
    Perreau P; Joubaud F; Cheguillaume J; Boyer J; Vernin H
    Sem Hop; 1972 Mar; 48(14):957-66. PubMed ID: 4339074
    [No Abstract]   [Full Text] [Related]  

  • 2. Liver disease, insulin antagonism and diabetes mellitus.
    Creutzfeldt W; Frerichs H; Kneer P
    Horm Metab Res; 1974; Suppl 4():135-42. PubMed ID: 4423508
    [No Abstract]   [Full Text] [Related]  

  • 3. [Changes of glycemia, insulinemia (IRI), and non-esterified free fatty acids during dynamic tests in a group of subjects with hepatic cirrhosis. The Rastinon test].
    Zandomeneghi R
    Minerva Med; 1970 Jan; 61(6):185-9. PubMed ID: 5412764
    [No Abstract]   [Full Text] [Related]  

  • 4. [Metabolic changes following glucose and tolbutamide loading in liver cirrhosis and their role in the pathogenesis of hepatogenic diabetes mellitus].
    Kopetz K; Wehrmann P
    Klin Wochenschr; 1970 Nov; 48(21):1265-76. PubMed ID: 5519414
    [No Abstract]   [Full Text] [Related]  

  • 5. [Changes in carbohydrate metabolism in liver cirrhosis. I. Carbohydrate intolerance].
    Santolaria Fernández F; González García C; González Reimers E; Pestana Pestana M; Jorge Hernández J; Batista López N; Hernández Nieto L; Bueno Gómez J
    Rev Esp Enferm Apar Dig; 1983 Jan; 63(1):18-27. PubMed ID: 6867415
    [No Abstract]   [Full Text] [Related]  

  • 6. [Behavior of plasma/insulin, somatropin and NEFA after intravenous administration of tolbutamide in hepatic cirrhosis].
    Greco AV; Ghirlanda G; Rebuzzi A; Altomonte L; Manna R
    Minerva Med; 1976 Nov; 67(54):3525-32. PubMed ID: 995300
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Changes in carbohydrate metabolism, plasmatic NEFA and immunoreactive insulin in hepatic cirrhosis].
    Gragnoli G; Pupillo A; Montagnani M; Bayeli PF
    Atti Accad Fisiocrit Siena Med Fis; 1968; 17(2):1373-90. PubMed ID: 5759915
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the behavior of carbohydrates and immunoreactive insulin in hepatic cirrhosis].
    Savastano A; Rocca F; Lodi G; Gobbi A
    Minerva Med; 1975 Nov; 66(80):4235-41. PubMed ID: 1196517
    [No Abstract]   [Full Text] [Related]  

  • 9. [Diabetes mellitus secondary to liver diseases. A review (author's transl)].
    Guillon J; Charbonnel B
    Diabete Metab; 1975 Sep; 1(3):191-9. PubMed ID: 791727
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Changes of glycemia, immunoreactive insulin and nonesterified free fatty acids during function tests in a group of subjects with liver cirrhosis].
    Zandomeneghi R; Sgarbi E; Piva R
    Minerva Gastroenterol; 1969; 15(4):191-4. PubMed ID: 5379887
    [No Abstract]   [Full Text] [Related]  

  • 11. Carbohydrate and fat metabolism in patients with pheochromocytoma.
    Spergel G; Bleicher SJ; Ertel NH
    N Engl J Med; 1968 Apr; 278(15):803-9. PubMed ID: 5642499
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disturbances of carbohydrate regulation in hepatic lesions].
    Magnenat P
    Helv Med Acta; 1970 Dec; 35(5):354-62. PubMed ID: 5501843
    [No Abstract]   [Full Text] [Related]  

  • 13. Glucose tolerance, free fatty acid, and serum insulin responses in patients with cirrhosis.
    Berkowitz D
    Am J Dig Dis; 1969 Oct; 14(10):691-9. PubMed ID: 4898689
    [No Abstract]   [Full Text] [Related]  

  • 14. [Carbohydrate and lipid metabolism disorders in early stages of essential hypertension as pathogenetic risk factors of arteriosclerosis].
    Baumann R
    Z Gesamte Inn Med; 1973 Jun; 28(12):Suppl:191-2 c. PubMed ID: 4729276
    [No Abstract]   [Full Text] [Related]  

  • 15. [Obesity and diabetes. I. Blood sugar, blood insulin and NEFA during glucose tolerance test in obese subjects].
    Torri A; Zandomeneghi R; Sgarbi E
    Endocrinol Sci Cost; 1969; 31(1):40-8. PubMed ID: 5402437
    [No Abstract]   [Full Text] [Related]  

  • 16. Oral contraceptive steroids and carbohydrate metabolism.
    Kulkarni HJ; Gaitonde BB
    Indian J Physiol Pharmacol; 1972 Jan; 16(1):23-9. PubMed ID: 5025961
    [No Abstract]   [Full Text] [Related]  

  • 17. [Relation between senile arteriosclerosis and diabetes. I. Glucose oral load test].
    Zandomeneghi R; Lucchi R
    Endocrinol Sci Cost; 1970 May; 31(2):119-26. PubMed ID: 5470187
    [No Abstract]   [Full Text] [Related]  

  • 18. [Diabetes mellitus and reduced glucose tolerance in liver cirrhosis].
    Sestoft L
    Nord Med; 1968 Aug; 80(33):1073-9. PubMed ID: 5685663
    [No Abstract]   [Full Text] [Related]  

  • 19. [Measurement of plasma insulin and growth hormone after oral glucose tolerance test in patients with alcoholic cirrhosis].
    Descos L; M'Bendi S; Sassolas G; Audigier JC; Sidiqian N; Faure A; Bizollon CA
    Arch Fr Mal App Dig; 1974; 63(1):17-24. PubMed ID: 4441222
    [No Abstract]   [Full Text] [Related]  

  • 20. Serum glucose, insulin, and growth hormone in chronic hepatic cirrhosis.
    Samaan NA; Stone DB; Eckhardt RD
    Arch Intern Med; 1969 Aug; 124(2):149-52. PubMed ID: 5797073
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 13.